People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 121 participants.
Also called NCT03520660
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 121 participants
- Registry
-
NCT03520660
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03520660. Non-randomized; no masking; primary purpose treatment. Start 2018-10-19 (actual); primary completion 2032-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
- Condition
- Diabetes Mellitus
- Condition
- Hepatitis C, Chronic
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Epclusa
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct03520660- Content hash
a190372947a70579787bea34d93ae7879889a699b4184c2ea2e544d2be2b9647